INE961O01016
INE961O01016
RAINBOW CHILDRENS MED LTD
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 126.83B EUR | 143.49B EUR | 117.98B EUR | 134.09B EUR |
Enterprise Value | 131.02B EUR | 143.49B EUR | 126.56B EUR | 134.09B EUR |
Valuation Multiples | ||||
Trailing P/E | 44.48x | 50.28x | 42.39x | 66.62x |
Forward P/E | 31.73x | -- | -- | -- |
Price to Sales | 6.97x | 7.88x | 6.93x | 10.79x |
Price to Book | 7.7x | -- | 7.16x | -- |
EV/Revenue | 7.2x | 7.88x | 7.43x | 10.79x |
EV/EBITDA | 22.46x | 23.46x | 21.52x | 30.6x |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -- | -- | -- | -- |